Polypharmacy in the treatment of people diagnosed with borderline personality disorder: repeated cross-sectional study using New Zealand's national databases

Overview of attention for article published in BJPsych Open, October 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet
twitter: 33 X users

bluesky: 1 Bluesky user

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 34 X posts from 33 X users, with an upper bound of 202,042 followers.

It's almost as if the diagnosis of BPD invites treatment that deviates from the evidence base rather than allowing access to it. https://t.co/yPMFsRuXdd

I suspect this is also occurring in many other countries: https://t.co/QeOVjxxc12

RT @JRBneuropsiq: "There is a large burden of psychotropic polypharmacy in people with borderline personality disorder. This is concerning…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 30 additional X posts.